Hepatitis B vaccine: HEPLISAV-B is 1st approval in US in 25 years, 1st two-shot vaccine
by Press Release from Outbreak News Today on (#37PGT)
On Thursday, Dynavax Technologies Corporation announced that the U.S. Food and Drug Administration (FDA) approved HEPLISAV-B [Hepatitis B Vaccine, Recombinant (Adjuvanted)] for prevention of infection caused by all known subtypes of hepatitis B virus in adults age 18 years and older. HEPLISAV-B is the first new hepatitis B vaccine in the United States in more than 25 years and the ["]
The post Hepatitis B vaccine: HEPLISAV-B is 1st approval in US in 25 years, 1st two-shot vaccine appeared first on Outbreak News Today.